XML 39 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Calculation of Earnings Per Share
9 Months Ended
Sep. 29, 2013
Calculation of Earnings Per Share  
Calculation of Earnings Per Share

5.              Calculation of Earnings Per Share

 

The calculations of basic earnings per common share and earnings per common share — assuming dilution are as follows (in thousands, except per-share data):

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

Sept. 29,

 

Sept. 23,

 

Sept. 29,

 

Sept. 23,

 

 

 

2013

 

2012

 

2013

 

2012

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per common share:

 

 

 

 

 

 

 

 

 

Net income, net of redeemable noncontrolling interests

 

$

14,276

 

$

13,031

 

$

50,732

 

$

44,301

 

Weighted average shares outstanding

 

21,591

 

23,268

 

21,855

 

23,685

 

Basic earnings per common share

 

$

0.66

 

$

0.56

 

$

2.32

 

$

1.87

 

 

 

 

 

 

 

 

 

 

 

Earnings per common share - assuming dilution:

 

 

 

 

 

 

 

 

 

Net income, net of redeemable noncontrolling interests

 

$

14,276

 

$

13,031

 

$

50,732

 

$

44,301

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

21,591

 

23,268

 

21,855

 

23,685

 

Dilutive effect of outstanding equity awards

 

493

 

453

 

526

 

422

 

Diluted weighted average shares outstanding

 

22,084

 

23,721

 

22,381

 

24,107

 

Earnings per common share - assuming dilution

 

$

0.65

 

$

0.55

 

$

2.27

 

$

1.84

 

 

The Company grants time-based restricted shares, which are participating securities. The Company evaluated earnings per common share under the “two class method” and determined there were no material differences from the amounts disclosed.

 

Shares subject to options to purchase common stock with an exercise price greater than the average market price are not included in the computation of earnings per common share — assuming dilution because the effect would be antidilutive. The weighted average number of shares subject to antidilutive options was 24,000 and 129,000 for the three and nine months ended September 29, 2013, respectively (none for the three and nine months ended September 23, 2012).